PuSH - Publikationsserver des Helmholtz Zentrums München

17 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Roll, W.* et al.: Multispectral optoacoustic tomography of benign and malignant thyroid disorders: A pilot study. J. Nucl. Med. 60, 1461-1466 (2019)
2.
Meles, S.K.* et al.: The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson’s disease. J. Nucl. Med. 59, 1437-1444 (2018)
3.
Schottelius, M.* et al.: Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer. J. Nucl. Med. 60, 71-78 (2018)
4.
Hankir, M.K.* et al.: Dissociation between brown adipose tissue 18F-FDG uptake and thermogenesis in uncoupling protein 1 deficient mice. J. Nucl. Med. 58, 1100-1103 (2017)
5.
Mendler, C.T.* et al.: Tumor uptake of anti-CD20 Fabs depends on tumor perfusion. J. Nucl. Med. 57, 1971-1977 (2016)
6.
Spielmann, V. ; Li, W.B. ; Zankl, M. ; Oeh, U. & Hoeschen, C.: Uncertainty quantification in internal dose calculations for seven selected radiopharmaceuticals. J. Nucl. Med. 57, 122-128 (2016)
7.
Tjalma, J.J.* et al.: Molecular-guided endoscopy targeting vascular endothelial growth factor A for improved colorectal polyp detection. J. Nucl. Med. 57, 480-485 (2016)
8.
Bézière, N. & Ntziachristos, V.: Optoacoustic imaging of naphthalocyanine: Potential for contrast enhancement and therapy monitoring. J. Nucl. Med. 56, 323-328 (2015)
9.
Notni, J.* et al.: Ga-68-Aquibeprin and Ga-68-Avebetrin for complementary, selective PET imaging of integrin subtypes alpha(5)beta(1) and alpha(v)beta(3). J. Nucl. Med. 56:58 (2015)
10.
van Berkel, A.* et al.: Semi-quantitative 123I-metaiodobenzylguanidine scintigraphy to distinguish pheochromocytoma and paraganglioma from physiological adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters. J. Nucl. Med. 56, 839-846 (2015)
11.
Trajkovic-Arsic, M.* et al.: Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancer. J. Nucl. Med. 55, 446-451 (2014)
12.
Gaertner, F.C.* et al.: Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model. J. Nucl. Med. 54, 2111-2117 (2013)
13.
Garcia-Allende, P. ; Glatz, J. ; Koch, M. & Ntziachristos, V.: Enriching the interventional vision of cancer with fluorescent and optoacoustic imaging. J. Nucl. Med. 54, 664-667 (2013)
14.
Giussani, A. et al.: A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients. J. Nucl. Med. 53, 985-993 (2012)
15.
Terwisscha van Scheltinga, A.G.* et al.: Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J. Nucl. Med. 52, 1778-1785 (2011)
16.
Buck, A.K.* et al.: Economic evaluation of PET and PET/CT in oncology: Evidence and methodologic approaches. J. Nucl. Med. 51, 401-412 (2010)
17.
Schreyögg, J. et al.: Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer. J. Nucl. Med. 51, 1668-1675 (2010)